Author:
Toure Offianan A,Assi Serge B,N’Guessan Tiacoh L,Adji Gbessi E,Ako Aristide B,Brou Marie J,Ehouman Marie F,Gnamien Laeticia A,Coulibaly M’Lanhoro AA,Coulibaly Baba,Beourou Sylvain,Bassinka Issiaka,Soumahoro Adama,Kadjo Florence,Tano Mea A
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference31 articles.
1. World Health Organization: Guidelines for the treatment of malaria. 2010, Geneva: WHO Press, 2
2. WHO: Methods for surveillance of antimalarial drug efficacy. 2009, World Health Organization: Geneva, [
http://whqlibdoc.who.int/publications/2009/9789241597531_eng.pdf
]
3. Dondorp AM, Yeung S, White L, Nguon C, Day NP, Socheat D, Von Seidlein L: Artemisinin resistance: current status and scenarios for containment. Nat Rev Microbiol. 2010, 8: 272-280.
4. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Ler Moo C, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NP, White NJ, Anderson TJ, Nosten F: Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012, 379: 1960-1966. 10.1016/S0140-6736(12)60484-X.
5. Faye B, Offianan AT, Ndiaye JL, Tine RC, Touré W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O: Efficacy and tolerability of artesunate- amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Trop Med Int Health. 2010, 15: 608-613.